Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Mar 1950 |
100 Clinical Results associated with Consolidated Midland Corp.
0 Patents (Medical) associated with Consolidated Midland Corp.
100 Deals associated with Consolidated Midland Corp.
100 Translational Medicine associated with Consolidated Midland Corp.